Adwoa Parker

1.3k total citations
29 papers, 471 citations indexed

About

Adwoa Parker is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Adwoa Parker has authored 29 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in General Health Professions, 10 papers in Public Health, Environmental and Occupational Health and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Adwoa Parker's work include Ethics in Clinical Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Adwoa Parker is often cited by papers focused on Ethics in Clinical Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Adwoa Parker collaborates with scholars based in United Kingdom, United States and Ireland. Adwoa Parker's co-authors include Peter Knapp, Peter Bower, Arabella Scantlebury, Jacqueline Martin‐Kerry, Catriona McDaid, Joanna L. Hudson, Rebecca Sheridan, Kath Wright, Barbara Kamm and Roy Bullingham and has published in prestigious journals such as PLoS ONE, Journal of Clinical Epidemiology and Annals of the Rheumatic Diseases.

In The Last Decade

Adwoa Parker

28 papers receiving 455 citations

Peers

Countries citing papers authored by Adwoa Parker

Since Specialization

Citations

This map shows the geographic impact of Adwoa Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adwoa Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adwoa Parker more than expected).

Fields of papers citing papers by Adwoa Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adwoa Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adwoa Parker. The network helps show where Adwoa Parker may publish in the future.

Co-authorship network of co-authors of Adwoa Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Adwoa Parker. A scholar is included among the top collaborators of Adwoa Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adwoa Parker. Adwoa Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Why do patients take part in research? An updated overview of systematic reviews of psychosocial barriers and facilitators 2025 ·Trials ·Peter Knapp, Peter Bower, (unknown), (unknown), (unknown), Su Golder, Chris Keyworth, Adwoa Parker, Rebecca Sheridan	1
2	Are retention strategies used in National Institute for Health and Care Research, Health Technology Assessment trials supported by evidence for their effectiveness? A systematic mapping review 2024 ·(unknown), Adwoa Parker, David Torgerson	0
3	Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme 2024 ·Health Technology Assessment ·Adwoa Parker, Catherine Arundel, Laura Clark, Elizabeth Coleman, Laura Doherty, Catherine Hewitt, David Beard, Peter Bower, Cindy Cooper, Lucy Culliford, Declan Devane, Richard Emsley, Sandra Eldridge, Sandra Galvin, Katie Gillies, Alan Montgomery, Chris Sutton, Shaun Treweek, David Torgerson	3
4	Can we achieve better trial recruitment by presenting patient information through multimedia? Meta-analysis of ‘studies within a trial’ (SWATs) 2023 ·BMC Medicine ·Vichithranie Madurasinghe, Peter Knapp, Sandra Eldridge, David Collier, Shaun Treweek, Jo Rick, Jonathan Graffy, Adwoa Parker, Chris Salisbury, David Torgerson, Kate Jolly, Manbinder Sidhu, Chris Fife‐Schaw, Mark A. Hull, Kirsty Sprange, Elizabeth Brettell, Sunil Bhandari, Alan Montgomery, Peter Bower	2
5	The PROMoting the USE of SWATs (PROMETHEUS) programme: Lessons learnt and future developments for SWATs 2022 ·Bristol Research (University of Bristol) ·Laura Clark, Catherine Arundel, Elizabeth Coleman, Laura Doherty, Adwoa Parker, Catherine Hewitt, David Beard, Peter Bower, Paul Brocklehurst, Cindy Cooper, Lucy Culliford, Declan Devane, Richard Emsley, Sandra Eldridge, Sandra Galvin, Katie Gillies, Alan Montgomery, Chris Sutton, Shaun Treweek, David Torgerson	9
6	Challenges and solutions to the implementation of studies within a trial: The experiences of the PROMETHEUS programme 2022 ·PubMed Central ·Catherine Arundel, Laura Clark, Elizabeth Coleman, Laura Doherty, Adwoa Parker, David Torgerson	3
7	PROMoting the use of studies within a trial (PROMETHEUS): Results and experiences from a large programme to evaluate the routine embedding of recruitment and retention strategies within randomised controlled trials routinely 2022 ·Bristol Research (University of Bristol) ·Laura Doherty, Adwoa Parker, Catherine Arundel, Laura Clark, Elizabeth Coleman, Catherine Hewitt, David Beard, Peter Bower, Paul Brocklehurst, Cindy Cooper, Lucy Culliford, Declan Devane, Richard Emsley, Sandra Eldridge, Sandra Galvin, Katie Gillies, Alan Montgomery, Chris Sutton, Shaun Treweek, David Torgerson	1
8	Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators 2020 ·Trials ·Rebecca Sheridan, Jacqueline Martin‐Kerry, Joanna L. Hudson, Adwoa Parker, Peter Bower, Peter Knapp	100
9	Timing of electronic reminders did not improve trial participant questionnaire response: a randomized trial and meta-analyses 2020 ·Journal of Clinical Epidemiology ·(unknown), Lucksy Kottam, Adwoa Parker, Stephen Brealey, Elizabeth Coleman, Ada Keding, Alex Mitchell, Matthew Northgraves, David Torgerson, Amar Rangan	6
10	Study within a trial (SWAT) protocol. Investigating the effect of personalised versus non-personalised study invitations on recruitment: An embedded randomised controlled recruitment trial 2020 ·Contemporary Clinical Trials Communications ·Joanne Woodford, (unknown), (unknown), Helena Grönqvist, Adwoa Parker, Catherine Arundel, Louise von Essén	7
11	Outcome domains and outcome measures used in studies assessing the effectiveness of interventions to manage non-respiratory sleep disturbances in children with neurodisabilities: a systematic review 2019 ·BMJ Open ·Catriona McDaid, Adwoa Parker, Arabella Scantlebury, Caroline Fairhurst, (unknown), Heather Elphick, Catherine Hewitt, Gemma Spiers, Megan Thomas, Bryony Beresford	6
12	The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial 2018 ·Trials ·Adwoa Parker, Peter Knapp, Shaun Treweek, (unknown), Roberta Littleford, Stephanie Gallant, Frank Sullivan, Stuart Schembri, Jo Rick, Jonathan Graffy, David Collier, Sandra Eldridge, Anne Kennedy, Peter Bower	12
13	Interagency collaboration models for people with mental ill health in contact with the police: a systematic scoping review 2018 ·BMJ Open ·Adwoa Parker, Arabella Scantlebury, Alison Booth, Jillian MacBryde, William J. Scott, Kath Wright, Catriona McDaid	38
14	Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review 2018 ·Health Technology Assessment ·Bryony Beresford, Catriona McDaid, Adwoa Parker, Arabella Scantlebury, Gemma Spiers, Caroline Fairhurst, Catherine Hewitt, Kath Wright, (unknown), Heather Elphick, Megan Thomas	30
15	Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol 2017 ·Inflammatory Bowel Diseases ·William J. Sandborn, Douglas C. Wolf, Gordana Kosutic, Adwoa Parker, Stefan Schreiber, Scott D. Lee, Bincy Abraham, Anita Afzali, Razvan Arsenescu, Alexandra Gutierrez, (unknown), Jason Coarse, Brian G. Feagan	20
16	Effectiveness of a training program for police officers who come into contact with people with mental health problems: A pragmatic randomised controlled trial 2017 ·PLoS ONE ·Arabella Scantlebury, Caroline Fairhurst, Alison Booth, Catriona McDaid, Nicola Moran, Adwoa Parker, Rebecca Payne, William J. Scott, David Torgerson, Martin Webber, Catherine Hewitt	28
17	Undertaking a randomised controlled trial in the police setting: methodological and practical challenges 2017 ·Trials ·Arabella Scantlebury, Catriona McDaid, Alison Booth, Caroline Fairhurst, Adwoa Parker, Rebecca Payne, (unknown), William J. Scott, David Torgerson, Catherine Hewitt	6
18	The PEG Moiety of Certolizumab Pegol is Rapidly Cleared From the Blood of Humans by the Kidneys Once it is Cleaved From the Fabʼ 2009 ·Inflammatory Bowel Diseases ·(unknown), Lloyd King, Adwoa Parker, Andrew Nesbitt	8
19	The PEG Moiety of Certolizumab Pegol is Rapidly Cleared from the Blood of Humans by the Kidneys Once it is Cleaved from the Fabʼ 2009 ·The American Journal of Gastroenterology ·(unknown), Lloyd King, Adwoa Parker, Andrew Nesbitt	1
20	Pharmacokinetics of Oral Mycophenolate Mofetil in Volunteer Subjects with Varying Degrees of Hepatic Oxidative Impairment 1996 ·The Journal of Clinical Pharmacology ·Adwoa Parker, Roy Bullingham, Barbara Kamm, Michael Hale	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact